A groundbreaking study has uncovered the crucial role of two proteins in the abnormal bone growth that can occur after injuries. This unexpected development, known as heterotopic ossification (HO), can lead to long-term pain and disability for patients. The research, led by Dr. Benjamin Levi, sheds light on the mysterious biological processes behind HO and offers hope for preventing this debilitating condition.
The Battle Within: Unraveling the Mystery of Abnormal Bone Growth
In the aftermath of severe injuries, our bodies embark on a remarkable journey of healing. However, for some individuals, this process takes an unfortunate turn, resulting in the formation of new bone inside soft tissues. This condition, HO, often arises after trauma, surgeries, or combat injuries, and can significantly impact a person's quality of life. Despite its severity, the underlying biological mechanisms have remained largely unexplained—until now.
Dr. Levi and his team at the Center for Organogenesis, University of Texas Southwestern, have made a significant breakthrough. They have identified two key proteins, thrombospondin 1 (TSP1) and thrombospondin 2 (TSP2), as central players in this abnormal bone growth. These proteins, it seems, have the power to reshape damaged tissue, inadvertently setting the stage for bone formation where it shouldn't be.
"Our findings reveal the critical role these proteins play in the healing process. By understanding how they influence tissue repair, we can potentially prevent this harmful complication," explains Dr. Levi.
The study, published in Bone Research, Volume 14, on January 19, 2026, delves into the molecular signals that guide tissue healing. Previous research hinted at the influence of changes in the extracellular matrix (ECM), but the specific factors remained elusive. Dr. Levi's team set out to identify these factors and understand how they shape the healing environment.
Using a mouse model involving burn and tendon injuries—a known trigger for HO—the researchers tracked cellular and tissue changes over time. Advanced genetic and imaging techniques, including single-cell RNA sequencing and spatial transcriptomics, were employed. High-resolution imaging analyzed collagen fibers, and three-dimensional scans revealed bone formation.
The results were intriguing. TSP1 was primarily produced by immune cells called macrophages at the injury's core, with lower levels detected in mesenchymal progenitor cells (MPCs), which can develop into bone-forming cells. In contrast, TSP2 was mainly produced by MPCs at the edges of the damaged area.
Furthermore, these proteins influenced collagen fiber arrangement. In normal healing, collagen is flexible and loosely organized. However, in injured tissue with active thrombospondin signaling, the fibers became tightly aligned, creating a structure conducive to bone growth. To test the proteins' significance, the team studied mice lacking both TSP1 and TSP2. In these mice, collagen fibers were disorganized, and abnormal bone growth was significantly reduced.
"By removing these proteins, we disrupted the supportive framework necessary for ectopic bone development. This led to a substantial decrease in harmful bone formation," Dr. Levi elaborates.
Scans confirmed that these mice had significantly smaller bone deposits in tendons and surrounding tissues, with their normal skeleton remaining unaffected. This suggests a potential strategy to reduce abnormal bone growth without interfering with healthy bone development.
The study also identified a regulatory protein, FUBP1, which controls TSP2 production. Reducing FUBP1 levels in laboratory-grown cells decreased TSP2 levels, weakening the signals that promote tissue remodeling. However, the authors caution that these findings are primarily based on animal models, and further research is needed to confirm their applicability to humans.
"HO can have a profound impact on patients' lives. By understanding the roles of TSP1 and TSP2 in HO formation, we aim to develop targeted therapies that prevent HO before it causes irreversible damage," Dr. Levi concludes.
This research opens new avenues for understanding and potentially treating HO, offering hope to those affected by this condition.
